Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial : Journal of the American Society of Nephrology

Journal Logo

Clinical Research: Chronic Kidney Disease

Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial

Provenzano, Michele1; Puchades, Maria Jesús2; Garofalo, Carlo1; Jongs, Niels3; D’Marco, Luis4; Andreucci, Michele5; De Nicola, Luca1; Gorriz, Jose Luis2; Heerspink, Hiddo J.L.3,* on behalf of the ROTATE-3 study group

Collaborators

Pennino, Luigi; De Gregorio, Ilaria; Polese, Lucio; Caturano, Alfredo; Minutolo, Roberto; Sasso, Ferdinando; Gagliardi, Ida; Zicarelli, Mariateresa; Crugliano, Giuseppina; Civera, Elena Gimenez; Panizo, Nayara; Sen, Taha; Xie, Di

Author Information
JASN 33(8):p 1569-1580, August 2022. | DOI: 10.1681/ASN.2022020207
  • Buy
  • Infographic
  • SDC

Abstract

Copyright © 2022 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid